Shares of Xylem Inc (NYSE:XYL) have been given an average rating of “Buy” by the fourteen research firms that are covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $71.70.
Several brokerages recently issued reports on XYL. Zacks Investment Research downgraded Xylem from a “buy” rating to a “hold” rating in a report on Tuesday. BMO Capital Markets reiterated a “buy” rating and issued a $83.00 price target on shares of Xylem in a report on Friday, January 26th. Canaccord Genuity reiterated a “hold” rating and issued a $75.00 price target on shares of Xylem in a report on Sunday, January 28th. Seaport Global Securities reiterated a “buy” rating and issued a $83.00 price target on shares of Xylem in a report on Friday, February 2nd. Finally, Oppenheimer increased their price target on Xylem to $82.00 and gave the company an “outperform” rating in a report on Friday, February 2nd.
In other Xylem news, Director Steven R. Loranger sold 47,712 shares of the firm’s stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $68.10, for a total value of $3,249,187.20. Following the transaction, the director now owns 68,843 shares of the company’s stock, valued at $4,688,208.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Tomas Brannemo sold 2,260 shares of Xylem stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $67.75, for a total value of $153,115.00. Following the sale, the insider now directly owns 10,975 shares in the company, valued at approximately $743,556.25. The disclosure for this sale can be found here. Insiders have sold 75,455 shares of company stock valued at $5,166,873 over the last 90 days. Insiders own 0.75% of the company’s stock.
Shares of Xylem (XYL) traded up $0.22 on Wednesday, hitting $72.78. The company had a trading volume of 606,411 shares, compared to its average volume of 1,101,269. The company has a quick ratio of 1.41, a current ratio of 1.88 and a debt-to-equity ratio of 0.87. The stock has a market cap of $12,918.63, a price-to-earnings ratio of 39.50, a P/E/G ratio of 1.37 and a beta of 1.20. Xylem has a twelve month low of $46.95 and a twelve month high of $76.81.
Xylem (NYSE:XYL) last issued its earnings results on Thursday, February 1st. The industrial products company reported $0.76 earnings per share for the quarter, hitting the consensus estimate of $0.76. The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.27 billion. Xylem had a return on equity of 17.95% and a net margin of 7.03%. The business’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period last year, the company posted $0.66 EPS. equities research analysts forecast that Xylem will post 2.91 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 15th. Stockholders of record on Thursday, February 15th will be paid a dividend of $0.21 per share. The ex-dividend date is Wednesday, February 14th. This is an increase from Xylem’s previous quarterly dividend of $0.18. This represents a $0.84 annualized dividend and a dividend yield of 1.15%. Xylem’s dividend payout ratio (DPR) is currently 39.13%.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.